CATX

Perspective Therapeutics, Inc.
$3.66 -7.11%

Recent alerts on CATX

All signals →
SEC filing CATX Updates Corporate Presentation, Files New Exhibit 99.1
1d ago
SEC filing CATX Announces 2026 Annual Meeting Voting Results, Elects 6 Directors, Ratifies Auditor, Approves Annual Say-on-Pay Frequency
5d ago
News Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet - Zacks Investment Research
14d ago
News Perspective Therapeutics Q4 2025 Earnings Preview
80d ago
News New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
104d ago
Scanner Unusual volume (1.9x average)
123d ago
News INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
136d ago
News Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
136d ago
News CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
136d ago
News Ouroboros Announces Leading $60M Series A Investment in Cytotheryx to Advance Cell Therapy Platform for Liver Disease
137d ago
News Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
144d ago
News Sustained Therapeutics Reports Positive Phase 2 Results for Its Long-Acting Non-Opioid Medication for Chronic Pain
145d ago
News Aperture Therapeutics Announces First-In-Class MMP9 Antisense Oligonucleotide Program for ALS
146d ago
News Intune Physical Therapy Acquires Epic Physical Therapy, Expanding Outpatient Physical Therapy Services in North Carolina
147d ago
News LoQus23 Therapeutics nominates LQT-23 as first-in-class, oral drug candidate for Huntington's Disease
147d ago
News Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
152d ago
News vTv Therapeutics Announces New Appointments to its Scientific Advisory Board
153d ago
News RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
153d ago
News Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2025 Financial Results
153d ago

Get push alerts for CATX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS